Stocks · Technology · Services-Prepackaged Software

BiomX Inc.

PHGE Clue Score33
United States Fiscal year ends December CIK 0001739174 Results filed 12 Nov 2025

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Reuven Yeganeh
17 Mar 2026
Director
Sold after exercise indirect
530,000
$5.00
$2.65M
Reuven Yeganeh
16 Mar 2026
Director
Sold after exercise indirect
450,000
$5.00
$2.25M
Reuven Yeganeh
13 Mar 2026
Director
Sold after exercise indirect
370,000
$5.00
$1.85M
Reuven Yeganeh
12 Mar 2026
Director
Sold after exercise indirect
300,000
$5.00
$1.50M
Reuven Yeganeh
11 Mar 2026
Director
Exercised, kept indirect
300,000
$2.00
$600.00K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,650,000
History held since 19 Dec 2018